Editorial: Gene Therapy in the CNS – Progress and Prospects for Novel Therapies

Marco Ledri; Andreas T. Sørensen; Merab Kokaia; David P.D. Woldbye; Casper R. Gøtzsche

doi:10.3389/fnmol.2021.778134

Editorial: Gene Therapy in the CNS – Progress and Prospects for Novel Therapies

Marco Ledri, Andreas T. Sørensen, Merab Kokaia, David P.D. Woldbye, Casper R. Gøtzsche

University of Copenhagen

Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial › Peer review

Originalspråk	engelska
Artikelnummer	778134
Tidskrift	Frontiers in Molecular Neuroscience
Volym	14
DOI	https://doi.org/10.3389/fnmol.2021.778134
Status	Published - 2021

Ämnesklassifikation (UKÄ)

Neurovetenskaper

Tillgång till dokument

10.3389/fnmol.2021.778134

Citera det här

@article{d70e413a8d77422aac07570fbe2925f0,

title = "Editorial: Gene Therapy in the CNS – Progress and Prospects for Novel Therapies",

keywords = "adeno-associated virus vector, central nervous system, CRISPR, gene therapy, genome editing, proof-of-concept",

author = "Marco Ledri and S{\o}rensen, {Andreas T.} and Merab Kokaia and Woldbye, {David P.D.} and G{\o}tzsche, {Casper R.}",

year = "2021",

doi = "10.3389/fnmol.2021.778134",

language = "English",

volume = "14",

journal = "Frontiers in Molecular Neuroscience",

issn = "1662-5099",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Editorial

T2 - Gene Therapy in the CNS – Progress and Prospects for Novel Therapies

AU - Ledri, Marco

AU - Sørensen, Andreas T.

AU - Kokaia, Merab

AU - Woldbye, David P.D.

AU - Gøtzsche, Casper R.

PY - 2021

Y1 - 2021

KW - adeno-associated virus vector

KW - central nervous system

KW - CRISPR

KW - gene therapy

KW - genome editing

KW - proof-of-concept

U2 - 10.3389/fnmol.2021.778134

DO - 10.3389/fnmol.2021.778134

M3 - Debate/Note/Editorial

C2 - 34744628

AN - SCOPUS:85118609450

VL - 14

JO - Frontiers in Molecular Neuroscience

JF - Frontiers in Molecular Neuroscience

SN - 1662-5099

M1 - 778134

ER -